Published in Emerg Infect Dis on July 01, 2005
West Nile virus: review of the literature. JAMA (2013) 2.79
Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Proc Natl Acad Sci U S A (2007) 1.71
Aseptic meningitis and viral myelitis. Neurol Clin (2008) 1.49
West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis (2006) 1.35
Neuromuscular manifestations of west nile virus infection. Front Neurol (2012) 1.34
Emerging viral infections of the central nervous system: part 1. Arch Neurol (2009) 1.28
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Clinical manifestations and outcomes of West Nile virus infection. Viruses (2014) 1.05
Emerging infectious determinants of chronic diseases. Emerg Infect Dis (2006) 0.94
Current trends in West Nile virus vaccine development. Expert Rev Vaccines (2014) 0.93
Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol (2009) 0.90
Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus. J Neurovirol (2010) 0.90
Autonomic nervous dysfunction in hamsters infected with West Nile virus. PLoS One (2011) 0.88
West Nile virus neuroinvasive disease: neurological manifestations and prospective longitudinal outcomes. BMC Infect Dis (2014) 0.86
Prognosis of West Nile virus associated acute flaccid paralysis: a case series. J Med Case Rep (2011) 0.84
Acute flaccid myelitis: A clinical review of US cases 2012-2015. Ann Neurol (2016) 0.83
Experimental reovirus-induced acute flaccid paralysis and spinal motor neuron cell death. J Neuropathol Exp Neurol (2008) 0.83
A review of vaccine approaches for West Nile virus. Int J Environ Res Public Health (2013) 0.83
The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system. Arch Virol (2012) 0.83
Autoimmunity-related demyelination in infection by Japanese encephalitis virus. J Biomed Sci (2011) 0.82
Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barré Syndrome: Systematic Review. PLoS Med (2017) 0.81
North American encephalitic arboviruses. Neurol Clin (2008) 0.81
Fatal neurological respiratory insufficiency is common among viral encephalitides. J Infect Dis (2013) 0.80
Is initial preservation of deep tendon reflexes in West Nile Virus paralysis a good prognostic sign? Neurol Asia (2014) 0.75
West Nile virus presenting as flaccid paralysis: Case report and literature review. Radiol Case Rep (2015) 0.75
Estimating the economic impact of a possible equine and human epidemic of West Nile virus infection in Belgium. Euro Surveill (2016) 0.75
Neuroepidemiology and the epidemiology of viral infections of the nervous system. Handb Clin Neurol (2014) 0.75
Clinical characteristics and functional outcome of patients with West Nile neuroinvasive disease in Serbia. J Neurol (2014) 0.75
Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology (2017) 0.75
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Neurologic manifestations and outcome of West Nile virus infection. JAMA (2003) 4.61
A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med (2002) 3.87
The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis (2000) 3.86
West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ (2003) 3.03
Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol (2002) 3.02
Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34
Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics (2000) 2.20
Poliomyelitis due to West Nile virus. N Engl J Med (2002) 1.86
The distribution of the permanent paralysis in the lower limb in poliomyelitis; a clinical and pathological study. J Bone Joint Surg Br (1955) 1.83
West Nile virus infection: a new acute paralytic illness. Neurology (2003) 1.78
Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol (2003) 1.72
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Guillain-Barré syndrome: An unusual presentation of West Nile virus infection. Neurology (2000) 1.19
Histopathologically proven poliomyelitis with quadriplegia and loss of brainstem function due to West Nile virus infection. Clin Infect Dis (2003) 1.08
An analysis of residual disabilities (paralysis and crippling) among 100,000 poliomyelitis patients: with special reference to the rehabilitation of postpoliomyelitis patients. Arch Phys Med Rehabil (1958) 1.06
West Nile Virus Myelitis. Spinal Cord (2001) 1.04
Transient parkinsonism in West Nile virus encephalitis. Am J Med (2003) 1.03
Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve (2003) 0.99
Respiratory paralysis as a presenting symptom in Japanese encephalitis--a case report. Zhonghua Yi Xue Za Zhi (Taipei) (1989) 0.95
Natural and nosocomial infection in a patient with West Nile encephalitis and extrapyramidal movement disorders. Clin Infect Dis (2003) 0.92
Acute anterior myelitis complicating West Nile fever. Arch Neurol (1979) 0.92
Respiratory dysfunction in Guillain-Barré syndrome. Clin Chest Med (1994) 0.91
Value of second lumbar puncture in confirming a diagnosis of aseptic meningitis. A prospective study. Arch Neurol (1979) 0.84
Absolute neutrophil count in aseptic and bacterial meningitis related to time of lumbar puncture. Pediatr Neurol (2003) 0.83
Facial paralysis in poliomyelitis; a follow-up of 58 patients. Pediatrics (1957) 0.80
Phrenic stimulation in the treatment of acute bulbar poliomyelitis. J Am Med Assoc (1954) 0.79
Respiratory poliomyelitis: a follow-up study. Can Med Assoc J (1984) 0.79
Facial paralysis in poliomyelitis; report of 3 patients with unusual delayed paralysis. Neurology (1959) 0.79
Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med (2009) 17.89
Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med (2004) 8.54
West Nile virus. Lancet Infect Dis (2002) 7.97
Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis (2005) 6.09
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med (2003) 4.95
West Nile virus: a primer for the clinician. Ann Intern Med (2002) 4.81
Neurologic manifestations and outcome of West Nile virus infection. JAMA (2003) 4.61
Chikungunya virus in US travelers returning from India, 2006. Emerg Infect Dis (2007) 3.87
CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med (2006) 3.57
Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med (2003) 3.37
Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ (2011) 3.35
Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis (2003) 3.17
Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis (2005) 3.15
Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol (2002) 3.02
The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis (2004) 2.86
West Nile virus. JAMA (2003) 2.76
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis (2003) 2.34
West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis (2006) 2.30
Modeling relationships between climate and the frequency of human plague cases in the southwestern United States, 1960-1997. Am J Trop Med Hyg (2002) 2.13
Differential virulence of West Nile strains for American crows. Emerg Infect Dis (2004) 2.11
Dengue outbreak in Key West, Florida, USA, 2009. Emerg Infect Dis (2012) 2.04
Bartonella tamiae sp. nov., a newly recognized pathogen isolated from three human patients from Thailand. J Clin Microbiol (2007) 1.92
The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med (2005) 1.88
Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies. Clin Diagn Lab Immunol (2005) 1.87
West Nile virus economic impact, Louisiana, 2002. Emerg Infect Dis (2004) 1.83
Experimental infection of horses with West Nile virus. Emerg Infect Dis (2002) 1.81
Genetic variation in OAS1 is a risk factor for initial infection with West Nile virus in man. PLoS Pathog (2009) 1.81
West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis (2006) 1.76
Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion (2002) 1.74
Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis (2010) 1.67
Screening the United States blood supply for West Nile Virus: a question of blood, dollars, and sense. PLoS Med (2006) 1.61
Increased recognition of Powassan encephalitis in the United States, 1999-2005. Vector Borne Zoonotic Dis (2008) 1.59
Early-season avian deaths from West Nile virus as warnings of human infection. Emerg Infect Dis (2003) 1.54
Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep (2002) 1.48
Risk factors for alveolar echinococcosis in humans. Emerg Infect Dis (2004) 1.46
Manifestations of West Nile neuroinvasive disease. Rev Med Virol (2006) 1.45
Epidemiology of neuroinvasive arboviral disease in the United States, 1999-2007. Am J Trop Med Hyg (2008) 1.43
West Nile virus neuroinvasive disease incidence in the United States, 2002-2006. Vector Borne Zoonotic Dis (2008) 1.39
Detection of West Nile virus-infected mosquitoes and seropositive juvenile birds in the vicinity of virus-positive dead birds. Am J Trop Med Hyg (2002) 1.36
Neuroinvasive disease and West Nile virus infection, North Dakota, USA, 1999-2008. Emerg Infect Dis (2012) 1.35
West Nile Virus-associated flaccid paralysis outcome. Emerg Infect Dis (2006) 1.35
Tularemia on Martha's Vineyard: seroprevalence and occupational risk. Emerg Infect Dis (2003) 1.34
Assessing the amount of heterogeneity in random-effects meta-analysis. Biom J (2006) 1.32
Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.32
Molecular subtyping of Treponema pallidum from North and South Carolina. J Clin Microbiol (2005) 1.30
West Nile virus epidemic, northeast Ohio, 2002. Emerg Infect Dis (2005) 1.30
West Nile fever characteristics among viremic persons identified through blood donor screening. J Infect Dis (2010) 1.26
Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol (2004) 1.26
Human plague in the southwestern United States, 1957-2004: spatial models of elevated risk of human exposure to Yersinia pestis. J Med Entomol (2007) 1.25
Early season crow mortality as a sentinel for West Nile virus disease in humans, northeastern United States. Vector Borne Zoonotic Dis (2002) 1.24
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection. PLoS Negl Trop Dis (2012) 1.18
Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion (2003) 1.18
West Nile virus infection among pregnant women in a northern Colorado community, 2003 to 2004. Pediatrics (2006) 1.17
Residence-linked human plague in New Mexico: a habitat-suitability model. Am J Trop Med Hyg (2007) 1.17
Evaluation of a diagnostic algorithm using immunoglobulin M enzyme-linked immunosorbent assay to differentiate human West Nile Virus and St. Louis Encephalitis virus infections during the 2002 West Nile Virus epidemic in the United States. Clin Diagn Lab Immunol (2004) 1.14
Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. Vector Borne Zoonotic Dis (2011) 1.13
Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis (2003) 1.13
Effect of Hurricane Katrina on arboviral disease transmission. Emerg Infect Dis (2007) 1.12
Prolonged Detection of Zika Virus RNA in Pregnant Women. Obstet Gynecol (2016) 1.12
Risk factors for infection during a dengue-1 outbreak in Maui, Hawaii, 2001. Trans R Soc Trop Med Hyg (2005) 1.11
Persons with early syphilis identified through blood or plasma donation screening in the United States. J Infect Dis (2002) 1.08
Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis (2006) 1.08
Ultrahigh resolution optical biopsy with endoscopic optical coherence tomography. Opt Express (2004) 1.08
Catheter-based infrared light scanner as a tool to assess conduit quality in coronary artery bypass surgery. J Thorac Cardiovasc Surg (2006) 1.07
Novel arenavirus infection in humans, United States. Emerg Infect Dis (2011) 1.07
Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 1.06
Fatal West Nile virus encephalitis in a renal transplant recipient. Am J Clin Pathol (2004) 1.06
Assessing the risk of international spread of yellow fever virus: a mathematical analysis of an urban outbreak in Asuncion, 2008. Am J Trop Med Hyg (2012) 1.06
Cross-sectional study on influenza vaccination, Germany, 1999-2000. Emerg Infect Dis (2002) 1.05
Estimation of the impact of a Japanese encephalitis immunization program with live, attenuated SA 14-14-2 vaccine in Nepal. Am J Trop Med Hyg (2013) 1.05
Cost-effectiveness of West Nile virus vaccination. Emerg Infect Dis (2006) 1.04
Quantification of West Nile virus in vector mosquito saliva. J Am Mosq Control Assoc (2005) 1.03
Evaluation of three immunoglobulin M antibody capture enzyme-linked immunosorbent assays for diagnosis of Japanese encephalitis. Am J Trop Med Hyg (2007) 1.01
Projecting Month of Birth for At-Risk Infants after Zika Virus Disease Outbreaks. Emerg Infect Dis (2016) 0.99
Zika Virus. N Engl J Med (2016) 0.99